Newsroom

Newsroom

Press Releases

1 of 1

Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
October 7, 2025
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
September 10, 2025
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
August 18, 2025
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
July 23, 2025
Waldencast Reports Q1 2025 Financial Results
May 13, 2025
Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast
May 6, 2025

Media Library

1 of 1